Gene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for ...

Bionano projects full-year 2025 revenues to be in the range of $29 million to $32 million, supported by its strategic focus on routine users. First-quarter 2025 revenues are expected to range from ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue ...

Conference call today, March 31, 2025 at 4:30 PM ETSAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and ...

Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday. Erica Kollmann Over $1M Bet On Bioventus ...

SAN DIEGO, March 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study published in the American Journal of Hematology demonstrating the potential utility of ...

Bionano will host a webinar on optical genome mapping's implications for acute myeloid leukemia, featuring Dr. Guilin Tang's insights. Bionano Genomics, Inc. has announced a webinar to be held on ...

SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American College of Medical Genetics and Genomics (ACMG) Annual ...

Good day, and welcome to the Bionano Fourth Quarter 2024 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...